Megan Ryan
About Megan Ryan
Megan Ryan serves as the Clinical Trial Operations and Innovation Director at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), where she coordinates the Small Business Program to promote innovation and technology development. She has extensive experience in clinical trials, having previously worked at Merck, the National Institutes of Health, and GenVec.
Current Role at National Institutes of Health
Megan Ryan serves as the Clinical Trial Operations and Innovation Director at the National Institutes of Health (NIH) since 2020. In this role, she is responsible for coordinating the Small Business Program at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Her focus is on fostering innovation and technology development within clinical trial operations. This position allows her to leverage her extensive experience in clinical trials and technology to enhance operational efficiency and drive advancements in research.
Previous Experience at National Institutes of Health
Prior to her current position, Megan Ryan worked at the National Institutes of Health for 13 years, from 2007 to 2020. During this time, she held the roles of Clinical Trials Specialist and Technology Development Coordinator. In these capacities, she contributed to the development and implementation of clinical trials, focusing on the integration of technology to improve research outcomes. Her long tenure at NIH provided her with a deep understanding of clinical operations and regulatory requirements.
Consulting Experience at Merck
Megan Ryan worked as a consultant at Merck from 2008 to 2010. During her two years at the company, she provided expertise in clinical trial processes and operations. This experience contributed to her understanding of the pharmaceutical industry's approach to clinical research and development, further enhancing her skills in managing complex clinical trials.
Educational Background
Megan Ryan holds multiple degrees that support her expertise in clinical operations and data analysis. She earned an MBA from the University of Maryland Global Campus, completing her studies from 2010 to 2012. Additionally, she studied at The Johns Hopkins University - Carey Business School, where she focused on Data Mining and also achieved an MBA from 2008 to 2010. Earlier, she obtained a Bachelor of Science in Biology from Towson University, studying from 1995 to 1999. This educational foundation underpins her professional roles in clinical trials and technology development.
Early Career at GenVec
Megan Ryan began her career at GenVec, where she worked as a Process Development Researcher from 1999 to 2001. In this role, she was involved in the development of processes related to biopharmaceuticals. This early experience in research and development provided her with a solid foundation in the scientific principles that underpin clinical trials and technology innovation.